Liraglutide (Victoza): A Human GLP-1 Analog for Once-Daily Use Liraglutide is a modified human GLP-1 analog essentially, it has the same amino acid sequence as human GLP-1 (7-37) except for two modifications: an arginine substitution at one position and a C-16 fatty acid chain attached via a spacer to Lysine at position 26 ( [111] )
Dual and triple incretin-based co-agonists: novel therapeutics for obesity and diabetes
Generic escitalopram may be appropriate for some people, but substitution depends on your treatment instructions and clinical situation
Amylin agonism Amylin is co-secreted with insulin from the -cells of the pancreas and plays a key role in postprandial satiety regulation (Fig
Both are known to treat obesity or overweight, aiding in weight loss, with an average decrease in body weight of 14.9%.* Your BMI is used to determine eligibility for one of our GLP-1 Plans
Contribution statement FX contributed to the study design, acquisition and interpretation of data, and drafting and revising of the article